Advertisement

Orthopedic

Advertisement

Histogenics, a biotech company focused on developing an implantable tissue repair platform for cartilage damage to the knee, filed with the U.S. Securities and Exchange Commission to raise up to $65 million in an initial public offering, according to a…

Advertisement